Protocatechuic Acid

Protocatechuic Acid

SCHEMBL4531319

CNc1ccc(O)c(O)c1.O=C(O)c1ccc(O)c(O)c1

nearest known ligand 0.68

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 4/20 0.68
CA1 P00915 4/20 0.68
CA2 P00918 4/20 0.68
CA7 P43166 4/20 0.68
CA9 Q16790 4/20 0.68
CA14 Q9ULX7 4/20 0.68
KDM4E B2RXH2 3/20 0.68
GAA P10253 2/20 0.68
POLB P06746 1/20 0.68
MAPT P10636 1/20 0.68
CA4 P22748 1/20 0.68
CA6 P23280 1/20 0.68
PTGS2 P35354 1/20 0.68
L3MBTL1 Q9Y468 1/20 0.68
TOP1 P11387 3/20 0.53
XDH P47989 1/20 0.50
HTT P42858 1/20 0.47
HDAC6 Q9UBN7 1/20 0.47
DBH P09172 1/20 0.46
RECQL P46063 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Protocatechuic Acid SCHEMBL30030432 0.82 CA12 (1.00) CA12CA1CA2CA7CA9
Protocatechuic Acid SCHEMBL29350008 0.82 CA12 (1.00) CA12CA1CA2CA7CA9
SCHEMBL84733 0.82 ARG1 (0.48) CA1CA2KDM4EMAPTCA4
Protocatechuic Acid SCHEMBL27815804 0.82 CA12 (1.00) CA12CA1CA2CA7CA9
Protocatechuic Acid SCHEMBL39435 0.82 CA12 (1.00) CA12CA1CA2CA7CA9
Protocatechuic Acid SCHEMBL29446274 0.81 CA12 (0.86) CA12CA1CA2CA7CA9
Protocatechuic Acid SCHEMBL28721393 0.81 CA12 (0.86) CA12CA1CA2CA7CA9
Protocatechuic Acid SCHEMBL23495982 0.80 CA12 (0.95) CA12CA1CA2CA7CA9
Protocatechuic Acid SCHEMBL2274950 0.80 CA12 (0.95) CA12CA1CA2CA7CA9
Bromide SCHEMBL28351801 0.80 ARG1 (0.47) CA1CA2KDM4EMAPTCA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090111863-A1 Compounds, Compositions and Methods for the Treatment of Beta-Amyloid Diseases and Synucleinopathies PROTAMED, INC. 2009-04-30 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090111863-A1 Compounds, Compositions and Methods for the Treatment of Beta-Amyloid Diseases and Synucleinopathies SNCA, PARK7, APP CA12 3773/4885CA1 3723/4885CA2 4294/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.